ARNI, LBBB, COVID-19 and various other topics

QR Code

ARNI, LBBB, COVID-19 and various other topics

Enregistré dans:

Détails bibliographiques
Auteur principal:	Çetin Erol
Format:	article
Langue:	EN
Publié:	KARE Publishing 2021
Sujets:	Diseases of the circulatory (Cardiovascular) system RC666-701
Accès en ligne:	https://doaj.org/article/cbec6e9062b84d6bbbbd3b71f8fe3f17
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Safety and effectiveness of angiotensin receptor-neprilysin inhibitors (ARNI) in patients with heart failure with preserved ejection fraction (HFPEF) – ‘ARNI-preserved’ study
par: Pankaj Jariwala, et autres
Publié: (2021)

GLP-1, SGLT-2, new devices for interventional cardiologists
par: Çetin Erol
Publié: (2021)

Studies and Reviews on Central Sleep Apnea, Endovascular Therapy, Robotic Surgery, and the associated Clinical and Genetic Characteristics in Cardiology
par: Çetin Erol
Publié: (2021)

Ramadan, TURKMI, REALITY HF, and so on…0
par: Çetin Erol
Publié: (2021)

Carotid artery stenting, new devices and techniques for interventional cardiology and atrial fibrillation
par: Çetin Erol
Publié: (2021)

Colchicine, fragmented QRS, coronavirus disease 2019, and more
par: Çetin Erol
Publié: (2021)

Energy drinks, pulmonary hypertension, and many more
par: Çetin Erol
Publié: (2021)

New impact factor and many new studies
par: Çetin Erol
Publié: (2021)

Miscellaneous attractive studies
par: Çetin Erol
Publié: (2021)

New year and our 20th Anniversary, Thomas F. Lüscher, pulmonary hypertension
par: Çetin Erol
Publié: (2021)

Fragmented QRS is a marker of mortality in patients with severe COVID-19: A retrospective observational study
par: İbrahim Halil Özdemir, et autres
Publié: (2021)

The effectiveness and tolerability of switching Indian patients from sacubitril/valsartan, ARNI to perindopril in heart failure with reduced ejection fraction. [Efficient study]
par: Pankaj Jariwala, et autres
Publié: (2021)

Perimyocarditis Following COVID-19 Vaccination
par: Mariana Tinoco, et autres
Publié: (2021)

COVID-19 Pandemic and Cardiovascular Disease
par: Aniket S Rali, et autres
Publié: (2020)

Diagnosis of Takotsubo syndrome in the COVID-19 era
par: Kristian Rivera, et autres
Publié: (2021)

Diagnosis of Takotsubo syndrome in the COVID-19 era
par: Kristian Rivera, et autres
Publié: (2021)

D-dimer, COVID-19 and Diabetes: A Correspondence
par: Sora Yasri PhD, et autres
Publié: (2021)

An Evaluation of Cardiology Virtual Care During the COVID-19 Pandemic
par: Kate E. Sanderson, MBA, et autres
Publié: (2021)

Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19
par: Rhian M. Touyz, MBBCh, PhD, et autres
Publié: (2021)

Diabetes and mortality in patients with COVID-19: Are we missing the link?
par: Marco Toselli2, et autres
Publié: (2021)

High-flow Nasal Cannula Oxygenation Revisited in COVID-19
par: Aniket S Rali, et autres
Publié: (2020)

COVID-19: a patient with cardiovascular disease at high risk
par: Irina E. Chazova, et autres
Publié: (2020)

Impact of colchicine on mortality in patients with COVID-19: A meta-analysis
par: Dimitrios A. Vrachatis, et autres
Publié: (2021)

Takotsubo Syndrome During the COVID-19 Pandemic: State-of-the-Art Review
par: Gassan Moady, MD, et autres
Publié: (2021)

Daily monitoring of D-dimer allows outcomes prediction in COVID-19
par: David M Smadja, et autres
Publié: (2021)

Spontaneous, severe, and diffuse coronary vasospasm in a patient with COVID-19
par: Mutlu Çağan Sümerkan, et autres
Publié: (2021)

Experience of adults with congenital heart disease during the COVID-19 pandemic
par: Mikyla Janzen, et autres
Publié: (2021)

Thrombosis in COVID-19: We still need to learn a lot
par: Cem Barçın
Publié: (2021)

Thrombosis, an important piece in the COVID-19 puzzle: From pathophysiology to therapy
par: Elena Bobescu, et autres
Publié: (2021)

Excess mortality in Greece during 2020: the role of COVID-19 and cardiovascular disease
par: Demosthenes Panagiotakos, et autres
Publié: (2021)

Rate of COVID-19 Infection in Patients With ST-Segment Elevation Myocardial Infarction
par: Maneesh Sud, MD, et autres
Publié: (2021)

Cardiovascular health and risk of hospitalization with COVID-19: A Mendelian Randomization study
par: Marina Cecelja, et autres
Publié: (2021)

Lockdown, slow down: impact of the COVID-19 pandemic on physical activity—an observational study
par: Joanne Kathryn Taylor, et autres
Publié: (2021)

Thrombosis After Adenovirus-Vectored COVID-19 Vaccination: A Concern on Underlying Illness
par: Rujittika Mungmunpuntipantip, et autres
Publié: (2021)

Postoperative Nosocomial COVID-19 Infection in Cardiac Surgery: An Uncommon Event With High Mortality Rate
par: Khalid Ridwan, MD, MSc, et autres
Publié: (2021)

Extensive Arterial, Venous and Intracardiac Thrombosis in a Patient After Recovery From COVID-19
par: Priyal Agarwal MD, et autres
Publié: (2021)

Transcatheter valve-in-valve implantation for sutureless bioprosthetic aortic paravalvular leak in the era of COVID-19
par: Şakir Arslan, et autres
Publié: (2021)

Treatment of Heart Failure with Sodium-Glucose Cotransporter 2 Inhibitors and Other Anti-diabetic Drugs
par: Thomas A Zelniker, et autres
Publié: (2019)

The non-infectious effects of COVID-19 were fierce with the weakest: What lessons did we learn?
par: Aline Meza-Ramos, et autres
Publié: (2021)

Interleukin-6 level is an independent predictor of right ventricular systolic dysfunction in patients hospitalized with COVID-19
par: Mehmet Erdoğan, et autres
Publié: (2021)